Related Experiment Video
Updated: May 8, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution
Yuan Gao1, Jieyu Zuo, Nadia Bou-Chacra
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Biomed Research International
|August 13, 2013
Summary
A modified cylinder method effectively assesses in vitro release kinetics for antituberculosis drug nanoparticles (NPs). This technique distinguishes drug release mechanisms, unlike the dialysis bag method, for rifampicin and moxifloxacin hydrochloride NPs.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Drug Delivery Systems
Background:
- Antituberculosis drugs like rifampicin (RIF) and moxifloxacin hydrochloride (MX) are crucial for treatment.
- Nanoparticles (NPs) offer potential for improved drug delivery, but their release kinetics require robust assessment.
- Evaluating in vitro drug release mechanisms is essential for characterizing nanocarrier performance.
Purpose of the Study:
- To evaluate the in vitro release kinetics of RIF and MX from gelatin and polybutyl cyanoacrylate (PBCA) NPs.
- To compare the efficacy of a modified cylinder method against the dialysis bag technique for assessing NP drug release.
- To determine if the modified cylinder method can differentiate between various drug release mechanisms and conditions.
Main Methods:
- Utilized a modified cylinder apparatus with a regenerated cellulose membrane for nanoparticle (NP) drug release studies.
- Employed rifampicin (RIF) and moxifloxacin hydrochloride (MX) as model antituberculosis drugs.
- Compared the modified cylinder method with the dialysis bag technique as a control, studying release in various media.
Main Results:
- The modified cylinder method revealed distinct release profiles and mechanisms for different NP systems (gelatin, PBCA).
- This method successfully differentiated between normal and forced in vitro release of drugs from gelatin NPs, even with enzymatic degradation.
- The dialysis bag technique failed to distinguish these release mechanisms under similar conditions.
Conclusions:
- The modified cylinder method is a superior tool for investigating in vitro drug release from antituberculosis drug-loaded nanoparticles (NPs).
- This technique provides a reliable method for performance testing of nanosized carrier systems, offering better mechanistic insights.
- The findings support the use of the modified cylinder method for quality control and development of nanomedicines.
Related Concept Videos
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...